CN1663961A - Separation and Purification Technology of Lactoferrin in Bovine Colostrum - Google Patents
Separation and Purification Technology of Lactoferrin in Bovine Colostrum Download PDFInfo
- Publication number
- CN1663961A CN1663961A CN 200410080264 CN200410080264A CN1663961A CN 1663961 A CN1663961 A CN 1663961A CN 200410080264 CN200410080264 CN 200410080264 CN 200410080264 A CN200410080264 A CN 200410080264A CN 1663961 A CN1663961 A CN 1663961A
- Authority
- CN
- China
- Prior art keywords
- lactoferrin
- resin
- separation
- whey
- ultrafiltration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000010445 Lactoferrin Human genes 0.000 title claims abstract description 46
- 108010063045 Lactoferrin Proteins 0.000 title claims abstract description 46
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 title claims abstract description 46
- 235000021242 lactoferrin Nutrition 0.000 title claims abstract description 46
- 229940078795 lactoferrin Drugs 0.000 title claims abstract description 46
- 210000003022 colostrum Anatomy 0.000 title claims abstract description 14
- 235000021277 colostrum Nutrition 0.000 title claims abstract description 14
- 241000283690 Bos taurus Species 0.000 title claims abstract description 10
- 238000000926 separation method Methods 0.000 title claims description 19
- 238000005516 engineering process Methods 0.000 title claims description 11
- 238000000746 purification Methods 0.000 title claims description 8
- 238000000034 method Methods 0.000 claims abstract description 38
- 239000011347 resin Substances 0.000 claims abstract description 36
- 229920005989 resin Polymers 0.000 claims abstract description 36
- 239000005862 Whey Substances 0.000 claims abstract description 19
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 19
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 19
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 19
- 239000000047 product Substances 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000008367 deionised water Substances 0.000 claims abstract description 10
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 10
- 239000003729 cation exchange resin Substances 0.000 claims abstract description 7
- 230000000694 effects Effects 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 7
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000004744 fabric Substances 0.000 claims abstract description 6
- 235000013305 food Nutrition 0.000 claims abstract description 5
- 238000004108 freeze drying Methods 0.000 claims abstract description 4
- 230000002378 acidificating effect Effects 0.000 claims abstract 3
- 238000004519 manufacturing process Methods 0.000 claims description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 230000008859 change Effects 0.000 claims description 6
- 238000010612 desalination reaction Methods 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 235000018102 proteins Nutrition 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 238000005342 ion exchange Methods 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 239000006227 byproduct Substances 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims 2
- 238000005341 cation exchange Methods 0.000 claims 1
- 238000011033 desalting Methods 0.000 claims 1
- 238000005265 energy consumption Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 8
- 239000003480 eluent Substances 0.000 abstract description 6
- 239000012535 impurity Substances 0.000 abstract description 5
- 239000012266 salt solution Substances 0.000 abstract description 5
- 239000005018 casein Substances 0.000 abstract description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract description 4
- 235000021240 caseins Nutrition 0.000 abstract description 4
- 238000001962 electrophoresis Methods 0.000 abstract description 3
- 230000008827 biological function Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract description 2
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 4
- 238000009776 industrial production Methods 0.000 description 4
- 238000009739 binding Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000020256 human milk Nutrition 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 238000005185 salting out Methods 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 238000005377 adsorption chromatography Methods 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 1
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102100038609 Lactoperoxidase Human genes 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- PNIWLNAGKUGXDO-UHFFFAOYSA-N Lactosamine Natural products OC1C(N)C(O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 PNIWLNAGKUGXDO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 235000020244 animal milk Nutrition 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- -1 carboxymethyl cation exchange resin Chemical compound 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- DOVBXGDYENZJBJ-ONMPCKGSSA-N lactosamine Chemical compound O=C[C@H](N)[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O DOVBXGDYENZJBJ-ONMPCKGSSA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229940080469 phosphocellulose Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
乳铁蛋白具有多种生物学功能,在食品及医疗行业应用潜力巨大。本发明建立了一套适合工业化的从牛初乳中分离纯化乳铁蛋白的方法,生产的乳铁蛋白具有成本低、工艺简单、设备投资低、无污染、产品纯度高、保持活性好等特点。具体方法为:①活化弱酸性阳离子交换树脂,制备成Na或K型;②初乳脱脂,沉淀酪蛋白备用;③在合适的pH和温度下将树脂和乳清混合,轻轻搅拌2-20h;④用滤布将树脂与乳清分离,并用去离子水清洗树脂,除去乳清和杂蛋白;⑤用合适的盐溶液洗脱乳铁蛋白;⑥洗脱液采用超滤工艺脱盐;⑦超滤浓缩液采用冷冻干燥方法干燥得乳铁蛋白产品;⑧运用SDS-PAGE电泳分析产品纯度。Lactoferrin has a variety of biological functions and has great application potential in the food and medical industries. The present invention establishes a method suitable for industrialization to separate and purify lactoferrin from bovine colostrum. The produced lactoferrin has the characteristics of low cost, simple process, low equipment investment, no pollution, high product purity, and good activity retention. . The specific method is: ① activate the weakly acidic cation exchange resin, and prepare it into Na or K type; ② skim the colostrum, and precipitate the casein for later use; ③ mix the resin and whey at a suitable pH and temperature, and stir gently for 2-20 hours ; ④ Use a filter cloth to separate the resin from the whey, and wash the resin with deionized water to remove whey and impurities; ⑤ Elute the lactoferrin with a suitable salt solution; ⑥ The eluent is desalted by ultrafiltration; ⑦ Ultrafiltration The concentrated solution is dried by freeze-drying method to obtain lactoferrin product; ⑧Using SDS-PAGE electrophoresis to analyze the product purity.
Description
本发明涉及一种从牛初乳中分离纯化乳铁蛋白的方法,特别是建立了一套适合工业化生产乳铁蛋白的新技术。该技术具有生产成本低,操作简单,无污染,不改变乳铁蛋白活性等特点,生产的乳铁蛋白纯度可达85%以上,乳铁蛋白的得率在70%以上。The invention relates to a method for separating and purifying lactoferrin from bovine colostrum, in particular establishing a set of new technologies suitable for industrial production of lactoferrin. The technology has the characteristics of low production cost, simple operation, no pollution, and does not change the activity of lactoferrin. The purity of the produced lactoferrin can reach more than 85%, and the yield of lactoferrin is more than 70%.
乳铁蛋白(Lactoferrin,简称Lf)是富含在初乳中的一种功能因子,它最初于1939年由Sorensen等在动物乳中发现,1953年Polis等在制备乳过氧化物酶时得到了它的粗制品,1960年Johansson和Montreuil等从人乳中首次分离出Lf。Lf因最先在乳汁中被发现而得名,后来的研究表明,它也广泛存在于动物体的泪液、唾液、汗液、胰液、胆汁、精液等内、外分泌液中,只是在乳汁中含量较高,如牛初乳中的Lf质量浓度为1g/L,而在其它分泌物中含量甚微。近代研究证明,Lf具有许多独特的生物学功能:增强铁的传递和吸收;广谱的抗菌性;免疫作用;抗氧化作用;促进肠道菌群的平衡;作为生长因子;抗炎症;抗病毒;抗癌症作用等。对Lf的分离、加工、综合利用的研究,已经成为食品界,特别是乳品界关心的热点。Lactoferrin (Lactoferrin, referred to as Lf) is a functional factor rich in colostrum. It was first discovered in animal milk by Sorensen et al. in 1939, and was obtained by Polis et al. in the preparation of lactoperoxidase in 1953. Its crude product, Johansson and Montreuil first isolated Lf from human milk in 1960. Lf got its name because it was first discovered in milk. Later studies showed that it also widely exists in the internal and external secretions of animals, such as tears, saliva, sweat, pancreatic juice, bile, semen, etc., but its content in milk is relatively low. High, such as the mass concentration of Lf in bovine colostrum is 1g/L, but the content in other secretions is very small. Modern studies have proved that Lf has many unique biological functions: enhancing iron delivery and absorption; broad-spectrum antibacterial properties; immune effects; antioxidant effects; promoting the balance of intestinal flora; as a growth factor; anti-inflammatory; antiviral ; Anti-cancer effect, etc. The research on the separation, processing and comprehensive utilization of Lf has become a hot spot in the food industry, especially in the dairy industry.
Lf是一种铁结合性糖蛋白,属于转铁蛋白家族。分子的主体是一个大约有700个氨基酸残基构成的、相对分子质量约为80,000Da的单肽链,并连接1~2个配糖体,其组成包括甘露糖、半乳糖、N-乙酰半乳糖胺、唾液酸、岩藻酸等。牛乳Lf由703氨基酸构成,等电点在8.0。Lf is an iron-binding glycoprotein that belongs to the transferrin family. The main body of the molecule is a single peptide chain consisting of about 700 amino acid residues and a relative molecular mass of about 80,000 Da, which is connected with 1 or 2 glycosides, and its composition includes mannose, galactose, N-acetyl half Lactosamine, sialic acid, fucoic acid, etc. Milk Lf is composed of 703 amino acids with an isoelectric point of 8.0.
由于Lf具有一些非凡的生理功能,自1960年以来人们就试着采用各种方法来制备Lf,人乳中Lf含量虽然丰富,但是依靠从人乳中提取Lf并不现实。商用Lf通常从牛乳中分离提取,特别是牛初乳和乳清,资源丰富,可实现规模化、商品化生产。物料的前期处理方法基本相同,都是采用新鲜牛初乳通过离心脱去脂肪(4℃,3000rpm,30min)得到脱脂乳,将脱脂乳稀释后,边搅拌边向其中加入1M盐酸溶液调整脱脂乳的pH值到4.6(酪蛋白的等电点),室温放置30min,离心除去酪蛋白(4℃,3000rpm,30min),得到的上清就是我们需要的乳清(或直接运用生产奶酪的副产物乳清),用它来分离Lf。Since Lf has some extraordinary physiological functions, people have tried various methods to prepare Lf since 1960. Although human milk is rich in Lf, it is not realistic to rely on extracting Lf from human milk. Commercial Lf is usually isolated and extracted from bovine milk, especially bovine colostrum and whey, which are rich in resources and can achieve large-scale and commercial production. The pre-processing method of the material is basically the same. Fresh bovine colostrum is used to remove fat by centrifugation (4°C, 3000rpm, 30min) to obtain skim milk. After diluting the skim milk, add 1M hydrochloric acid solution to it while stirring to adjust the skim milk. pH value to 4.6 (the isoelectric point of casein), placed at room temperature for 30min, centrifuged to remove casein (4°C, 3000rpm, 30min), the obtained supernatant is the whey we need (or directly use the by-product of cheese production whey), which was used to isolate Lf.
乳铁蛋白的分离纯化方法较多,常见的有吸附色谱法、亲和色谱法、固定化单克隆抗体法、超滤法、盐析法、离子交换法等。吸附色谱法是利用固相吸附剂通过与蛋白质分子相结合,利用不同物质和吸附剂结合力的差异性而将它们分离,其缺点是吸附容量小、效率低;亲和色谱法:亲和色谱是一种新兴的分离技术,它用来生产高纯度的Lf,该方法分离效果好纯度高,且没有生物活性损失,是生产医药用高纯度Lf最有效的方法之一,其缺点是成本昂贵,难以工业化生产;固定化单克隆抗体法:该方法实际上是利用抗原-抗体之间的高特异性结合反应而实现目标物的分离。载有单克隆抗体的免疫色谱是一种亲和力色谱法,它较成功的实现了Lf的一步分离,回收率达到97%,该方法的优点是分离效果好纯度高,抗体被固定可重复使用,其缺点是柱的制备工艺复杂,抗体成本昂贵(1000美元/克),难以工业化生产;超滤法:超滤是一种基本的膜分离技术,其原理是根据膜孔径不同可以实现不同分子质量和分子形状的大分子物质的分离,由于超滤法提供了不加热或不发生相变进行大分子质量组分的浓缩、分离的机会,非常适合热敏性的功能性组分的分离,但膜的污染和产品纯度较低难以满足生产的要求。盐析法:盐析法通常是利用饱和硫酸铵沉淀乳铁蛋白,该方法尽管生产成本简单,但由于乳清中添加硫酸铵带来了污染,产品的纯度也较低,制约了其应用。离子交换法:该方法原理是根据离子交换剂对不同的离子或离子化合物的结合力不同而实现目标物质的分离。Grove最早使用DEAE纤维素阴离子交换树脂分离出较纯的Lf成分,此后,他又开发出磷酸纤维素交换色谱法,并由Foley等对此法加以改进,得到的Lf的纯度为81%左右;羧甲基阳离子交换色谱法被应用于Lf和乳过氧化氢酶的分离。树脂能用0.2MNaOH和0.2MHCl再生,此法较DEAE纤维法更有效。尽管有人在尝试运用离子交换法生产乳铁蛋白,但由于所选树脂的种类、性能不同、交换条件不同,未能完全实现工业化生产。There are many separation and purification methods for lactoferrin, the common ones are adsorption chromatography, affinity chromatography, immobilized monoclonal antibody method, ultrafiltration method, salting out method, ion exchange method and so on. Adsorption chromatography is to use solid-phase adsorbents to combine with protein molecules, and to separate them by using the differences in the binding forces of different substances and adsorbents. The disadvantages are small adsorption capacity and low efficiency; affinity chromatography: affinity chromatography It is an emerging separation technology, which is used to produce high-purity Lf. This method has good separation effect and high purity without loss of biological activity. It is one of the most effective methods for producing high-purity Lf for medicine. Its disadvantage is that it is expensive , Difficult to industrial production; Immobilized monoclonal antibody method: This method actually uses the highly specific binding reaction between antigen-antibody to achieve the separation of the target. Immunochromatography loaded with monoclonal antibody is a kind of affinity chromatography, which successfully realizes the one-step separation of Lf, and the recovery rate reaches 97%. The disadvantage is that the preparation process of the column is complicated, the antibody cost is expensive (1000 US dollars/gram), and it is difficult to industrialize production; ultrafiltration method: ultrafiltration is a basic membrane separation technology, and its principle is that different molecular weights can be achieved according to different membrane pore sizes. Separation of macromolecular substances with molecular shapes, because ultrafiltration provides the opportunity to concentrate and separate macromolecular mass components without heating or phase change, it is very suitable for the separation of heat-sensitive functional components, but the membrane Pollution and low product purity are difficult to meet the requirements of production. Salting-out method: The salting-out method usually uses saturated ammonium sulfate to precipitate lactoferrin. Although the production cost of this method is simple, the addition of ammonium sulfate in whey brings pollution and the product has low purity, which restricts its application. Ion exchange method: The principle of this method is to achieve the separation of target substances according to the different binding forces of ion exchangers to different ions or ionic compounds. Grove first used DEAE cellulose anion exchange resin to separate relatively pure Lf components. After that, he developed phosphocellulose exchange chromatography and improved this method by Foley et al. The purity of Lf obtained was about 81%. Carboxymethyl cation exchange chromatography was applied to the separation of Lf and lactate catalase. The resin can be regenerated with 0.2M NaOH and 0.2M HCl, which is more effective than the DEAE fiber method. Although someone is trying to use the ion exchange method to produce lactoferrin, due to the different types, properties and exchange conditions of the selected resins, industrial production has not been fully realized.
本发明的目的在于:建立一套适合工业化从牛初乳中分离纯化乳铁蛋白的方法,纯化的乳铁蛋白纯度可达85%以上。The purpose of the present invention is to establish a method suitable for industrial separation and purification of lactoferrin from bovine colostrum, and the purity of the purified lactoferrin can reach more than 85%.
综合国内外的文献资料可知,乳铁蛋白的分离纯化工艺复杂,产品的纯度较低,产品的价格高,难以商品化。本发明选用羧甲基阳离子交换树脂,采用分批交换的方法,结合超滤脱盐和冷冻干燥工艺成功地建立了适合工业化生产乳铁蛋白的方法。该技术的主要特点为:Based on domestic and foreign literature, it can be known that the separation and purification process of lactoferrin is complex, the product has low purity, high product price, and is difficult to commercialize. The present invention selects carboxymethyl cation exchange resin, adopts batch exchange method, and combines ultrafiltration desalination and freeze-drying techniques to successfully establish a method suitable for industrial production of lactoferrin. The main features of this technology are:
①所选树脂符合食品卫生生产要求,分离纯化乳铁蛋白后,原料乳可继续利用,无任何污染。①The selected resin meets the food hygiene production requirements. After the separation and purification of lactoferrin, the raw milk can be continuously used without any pollution.
②该技术的工艺简单,设备投资低,适合工业化生产。②The technique of this technology is simple, the equipment investment is low, and it is suitable for industrialized production.
③该技术生产的乳铁蛋白,较好的保持了乳铁蛋白的活性,生产出的乳铁蛋白纯度较高,可以满足食品及医疗行业的需要。③The lactoferrin produced by this technology can better maintain the activity of lactoferrin, and the produced lactoferrin has higher purity, which can meet the needs of food and medical industries.
具体实施条件与发明制作方案Specific Implementation Conditions and Invention Production Scheme
1、牛初乳离心脱脂(3000rpm,30min),用1M的HCl调pH至4.6,沉淀酪蛋白,离心(3000rpm,30min),得乳清备用;1. Bovine colostrum was centrifuged and defatted (3000rpm, 30min), adjusted to pH 4.6 with 1M HCl, precipitated casein, centrifuged (3000rpm, 30min) to obtain whey for later use;
2、树脂活化,根据需要称取一定量树脂,用去离子水浸泡(常温下1-2天,或沸水1-2小时),再浸泡于10%NaCl溶液中,配制成Na型树脂;2. Resin activation, weigh a certain amount of resin as needed, soak in deionized water (1-2 days at room temperature, or 1-2 hours in boiling water), and then soak in 10% NaCl solution to prepare Na-type resin;
3、用1MNaOH将乳清pH调至5-8,加入Na型阳离子交换树脂,于0-50℃搅拌2-20h,用滤布抽滤分离树脂,用去离子水洗除杂蛋白,再用0.1-15%盐溶液(NaCl,KCl,CaCl2,MgCl2,NaCO3等)洗脱树脂,洗脱液超滤脱盐。浓缩液冷冻干燥得乳铁蛋白。3. Adjust the whey pH to 5-8 with 1M NaOH, add Na-type cation exchange resin, stir at 0-50°C for 2-20 hours, filter the resin with filter cloth, wash with deionized water to remove impurities, and then use 0.1 -15% salt solution (NaCl, KCl, CaCl 2 , MgCl 2 , NaCO 3 , etc.) to elute the resin, and the eluate is desalted by ultrafiltration. The concentrate is freeze-dried to obtain lactoferrin.
4、可用ELISA方法检测乳清中乳铁蛋白的交换情况,检测树脂的洗脱情况。产品经SDS-PAGE进行电泳,用凝胶成像系统分析其纯度。4. The exchange of lactoferrin in whey can be detected by ELISA method, and the elution of resin can be detected. The product was electrophoresed by SDS-PAGE, and its purity was analyzed by gel imaging system.
为了更加清楚的说明本发明,下面结合实施例进行详细说明:In order to illustrate the present invention more clearly, describe in detail below in conjunction with embodiment:
实施例1:称取2g CM-SEPHAROSE FF(PHARMACIA)树脂,加入200mL去离子水浸泡24h,收集树脂浸泡于10%的NaCl溶液中30min,制备成Na型树脂。将树脂加入5L脱脂乳清液中(pH值为6.9),于4℃轻轻搅拌交换8小时。用滤布分离收集树脂,经过交换后的脱脂乳清的pH、颜色、气味、感官均未发生变化。Embodiment 1: Weigh 2g of CM-SEPHAROSE FF (PHARMACIA) resin, add 200mL of deionized water to soak for 24h, collect the resin and soak in 10% NaCl solution for 30min, and prepare Na-type resin. The resin was added to 5L of skimmed whey (pH 6.9), and exchanged with gentle stirring at 4°C for 8 hours. The resin was separated and collected with a filter cloth, and the pH, color, smell and sensory of the exchanged skim whey did not change.
将收集的树脂用pH为6.9去离子水清洗,以除掉杂蛋白,然后再用5%的盐溶液洗脱树脂,用抽滤的方式将树脂和洗脱液分离,收集洗脱液进行超滤脱盐,超滤膜的截留分子量为3-5万,超滤压力为0.15-0.2MPa。经超滤The collected resin is washed with deionized water with a pH of 6.9 to remove foreign proteins, and then the resin is eluted with 5% salt solution, and the resin and the eluent are separated by suction filtration, and the eluent is collected for ultra- Filtration and desalination, the molecular weight cut-off of the ultrafiltration membrane is 30,000-50,000, and the ultrafiltration pressure is 0.15-0.2MPa. Ultrafiltered
脱盐后的乳铁蛋白浓缩液进行冷冻干燥,收集产品4.01g。产品经电泳分析纯度为86%,得率为69%。The desalted lactoferrin concentrate was freeze-dried, and 4.01 g of the product was collected. The purity of the product analyzed by electrophoresis was 86%, and the yield was 69%.
实施例2:称取30g SEPABEADS FP-CM13(MITSUBISHI KASEI)阳离子交换树脂进行活化,经平衡后装柱子(直径10cm),用蠕动泵将2L含10%KCl溶液过柱,然后用去离子水过柱,制备成K型阳离子交换树脂。然后将80L脱脂常乳乳清(pH6.6,4℃)以6L/h流速通过柱子进行交换,经交换过的乳清颜色,味道,均未发生变化。Embodiment 2: Take by weighing 30g SEPABEADS FP-CM13 (MITSUBISHI KASEI) cation exchange resin and carry out activation, install column (diameter 10cm) after balancing, with peristaltic pump, 2L containing 10% KCl solution is passed through the column, and then passed through with deionized water Column, prepared as K-type cation exchange resin. Then 80L of non-fat normal milk whey (pH6.6, 4°C) was exchanged through the column at a flow rate of 6L/h, and the color and taste of the exchanged whey remained unchanged.
将交换过的柱子先用去离子水过柱,除去乳清和杂蛋白,接着用15L含12%KCl溶液过柱洗脱乳铁蛋白,收集洗脱液15L。洗脱液经超滤脱盐和冷冻干燥后,得乳铁蛋白7.2g,经检测乳铁蛋白纯度为81%,得率为73%。The exchanged column was first passed through the column with deionized water to remove whey and impurity proteins, and then 15 L of 12% KCl solution was used to elute the lactoferrin through the column, and 15 L of the eluent was collected. After the eluate was desalted by ultrafiltration and freeze-dried, 7.2 g of lactoferrin was obtained. The purity of lactoferrin was detected to be 81%, and the yield was 73%.
实施例3:称取5g CM-SEPHADEX C-50(PHARMACIA)树脂,加入400mL去离子水浸泡24h,收集树脂浸泡于10%的NaCl溶液中30min,制备成Na型树脂230mL。将树脂加入20L脱脂初乳乳清液中(pH值为6.8),于4℃轻轻搅拌交换12小时。用滤布分离收集树脂,经过交换后的脱脂乳清的pH、颜色、气味、感官均未发生变化。Embodiment 3: Weigh 5g of CM-SEPHADEX C-50 (PHARMACIA) resin, add 400mL of deionized water and soak for 24h, collect the resin and soak in 10% NaCl solution for 30min, and prepare 230mL of Na-type resin. The resin was added to 20L of defatted colostrum whey (pH value was 6.8), and exchanged with gentle stirring at 4°C for 12 hours. The resin was separated and collected with a filter cloth, and the pH, color, smell and sensory of the exchanged skim whey did not change.
将收集的树脂用pH为6.8去离子水清洗,以除掉杂蛋白,然后先用1%的盐溶液洗脱树脂,以除去结合不牢的杂蛋白,再用5%的盐溶液洗脱树脂,用抽滤的方式将树脂和洗脱液分离,收集洗脱液进行超滤脱盐,超滤膜的截留分子量为3-5万,超滤压力为0.15-0.2MPa。经超滤脱盐后的浓缩液进行冷冻干燥,收集乳铁蛋白产品14.5g。产品经电泳分析纯度为92%,得率为65%。本实施例采用两步法洗脱树脂,产品的纯度有了较大提高,但产品的得率有所下降(产品的得率以初乳中乳铁蛋白含量为1g/L计算)。Wash the collected resin with deionized water with a pH of 6.8 to remove impurity proteins, then first elute the resin with 1% salt solution to remove unbound impurity proteins, and then elute the resin with 5% salt solution , the resin and eluent are separated by suction filtration, and the eluent is collected for ultrafiltration and desalination. The molecular weight cut-off of the ultrafiltration membrane is 30,000-50,000, and the ultrafiltration pressure is 0.15-0.2MPa. The concentrated solution after ultrafiltration and desalination was freeze-dried to collect 14.5 g of lactoferrin products. The purity of the product analyzed by electrophoresis was 92%, and the yield was 65%. The present embodiment adopts two-step method to elute the resin, and the purity of the product has been greatly improved, but the yield of the product has decreased (the yield of the product is calculated as 1 g/L of lactoferrin content in colostrum).
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410080264 CN1663961A (en) | 2004-09-29 | 2004-09-29 | Separation and Purification Technology of Lactoferrin in Bovine Colostrum |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410080264 CN1663961A (en) | 2004-09-29 | 2004-09-29 | Separation and Purification Technology of Lactoferrin in Bovine Colostrum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1663961A true CN1663961A (en) | 2005-09-07 |
Family
ID=35035295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410080264 Pending CN1663961A (en) | 2004-09-29 | 2004-09-29 | Separation and Purification Technology of Lactoferrin in Bovine Colostrum |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1663961A (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101477079A (en) * | 2009-01-06 | 2009-07-08 | 中国农业大学 | Active gel electrophoresis method for lactalbumin |
| CN101362792B (en) * | 2008-09-25 | 2011-07-20 | 上海交通大学 | Affinity separation polymer of lactoferrin and affinity purification method of lactoferrin |
| CN101294931B (en) * | 2008-06-24 | 2012-01-25 | 内蒙古蒙牛乳业(集团)股份有限公司 | Method for detecting content of beta-lactoglobulin in cow's milk |
| CN101256168B (en) * | 2008-04-22 | 2012-01-25 | 内蒙古蒙牛乳业(集团)股份有限公司 | Method for testing peroxidase content in cow's milk |
| CN102898516A (en) * | 2012-10-26 | 2013-01-30 | 浙江大学 | Method for purifying lactoferrin from milk serum by using an expanded bed adsorption technology |
| CN104109204A (en) * | 2013-04-16 | 2014-10-22 | 武汉禾元生物科技有限公司 | Method for separating and purifying recombinant human lactoferrins from paddy rice seeds |
| CN105566489A (en) * | 2015-12-10 | 2016-05-11 | 无锡科捷诺生物科技有限责任公司 | Method for preparing lactoferrin with different iron saturation degrees |
| CN110973345A (en) * | 2019-12-26 | 2020-04-10 | 吉林大学 | A kind of method for continuous separation and preparation of functional milk protein in colostrum |
| CN113105542A (en) * | 2021-04-15 | 2021-07-13 | 黑龙江飞鹤乳业有限公司 | Preparation method of lactoferrin |
| CN113387413A (en) * | 2021-05-19 | 2021-09-14 | 中核四0四有限公司 | Ion exchange method for uranium-containing wastewater treatment in nitric acid and carbonic acid mixed system |
| CN116600781A (en) * | 2020-12-22 | 2023-08-15 | 赛文西亚公司 | Novel process for the preparation of cationic whey protein isolate and products obtained therefrom |
| CN119930802A (en) * | 2025-04-09 | 2025-05-06 | 山东省农业科学院畜牧兽医研究所 | A kind of preparation method of lactoferrin |
| WO2025247269A1 (en) * | 2024-05-31 | 2025-12-04 | 江南大学 | Lactoferrin-rich active whey powder, high-activity infant formula, and preparation and use thereof |
-
2004
- 2004-09-29 CN CN 200410080264 patent/CN1663961A/en active Pending
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101256168B (en) * | 2008-04-22 | 2012-01-25 | 内蒙古蒙牛乳业(集团)股份有限公司 | Method for testing peroxidase content in cow's milk |
| CN101294931B (en) * | 2008-06-24 | 2012-01-25 | 内蒙古蒙牛乳业(集团)股份有限公司 | Method for detecting content of beta-lactoglobulin in cow's milk |
| CN101362792B (en) * | 2008-09-25 | 2011-07-20 | 上海交通大学 | Affinity separation polymer of lactoferrin and affinity purification method of lactoferrin |
| CN101477079A (en) * | 2009-01-06 | 2009-07-08 | 中国农业大学 | Active gel electrophoresis method for lactalbumin |
| CN102898516A (en) * | 2012-10-26 | 2013-01-30 | 浙江大学 | Method for purifying lactoferrin from milk serum by using an expanded bed adsorption technology |
| CN104109204A (en) * | 2013-04-16 | 2014-10-22 | 武汉禾元生物科技有限公司 | Method for separating and purifying recombinant human lactoferrins from paddy rice seeds |
| WO2014169760A1 (en) * | 2013-04-16 | 2014-10-23 | 武汉禾元生物科技有限公司 | Method for separating and purifying recombined human lactoferrin from rice seeds |
| CN105566489B (en) * | 2015-12-10 | 2021-07-30 | 无锡科捷诺生物科技有限责任公司 | Method for preparing lactoferrin with different iron saturation degrees |
| CN105566489A (en) * | 2015-12-10 | 2016-05-11 | 无锡科捷诺生物科技有限责任公司 | Method for preparing lactoferrin with different iron saturation degrees |
| CN110973345A (en) * | 2019-12-26 | 2020-04-10 | 吉林大学 | A kind of method for continuous separation and preparation of functional milk protein in colostrum |
| CN110973345B (en) * | 2019-12-26 | 2022-02-25 | 吉林大学 | Method for continuously separating and preparing functional lactoprotein in colostrum |
| CN116600781A (en) * | 2020-12-22 | 2023-08-15 | 赛文西亚公司 | Novel process for the preparation of cationic whey protein isolate and products obtained therefrom |
| CN113105542A (en) * | 2021-04-15 | 2021-07-13 | 黑龙江飞鹤乳业有限公司 | Preparation method of lactoferrin |
| CN113105542B (en) * | 2021-04-15 | 2023-06-30 | 黑龙江飞鹤乳业有限公司 | Lactoferrin preparation method |
| CN113387413A (en) * | 2021-05-19 | 2021-09-14 | 中核四0四有限公司 | Ion exchange method for uranium-containing wastewater treatment in nitric acid and carbonic acid mixed system |
| WO2025247269A1 (en) * | 2024-05-31 | 2025-12-04 | 江南大学 | Lactoferrin-rich active whey powder, high-activity infant formula, and preparation and use thereof |
| CN119930802A (en) * | 2025-04-09 | 2025-05-06 | 山东省农业科学院畜牧兽医研究所 | A kind of preparation method of lactoferrin |
| CN119930802B (en) * | 2025-04-09 | 2025-06-20 | 山东省农业科学院畜牧兽医研究所 | A kind of preparation method of lactoferrin |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4791193A (en) | Process for producing bovine lactoferrin in high purity | |
| AU661090B2 (en) | Process for the production of biologically active substances from milk and related raw materials | |
| EP0348508B1 (en) | Process for separating and purifying lactoferrin from milk using sulfate compound | |
| CN101724013B (en) | Method for separating and purifying immunoglobulin A, immunoglobulin G and lactoferrin from bovine colostrum in industrializing way | |
| CN1663961A (en) | Separation and Purification Technology of Lactoferrin in Bovine Colostrum | |
| US5077067A (en) | Process for the selective and quantitative elimination of lactoglobulins from a starting material containing whey proteins | |
| CN100417329C (en) | Whole separation process of liquid fresh milk | |
| JP2974434B2 (en) | Secretory component-containing composition | |
| JPH03109400A (en) | Method for separating, purifying and collecting iron binding protein | |
| WO2002028194A1 (en) | Process for recovering proteins from whey protein containing feedstocks | |
| CN120607599A (en) | Protein separation and preparation method | |
| CN100558242C (en) | A method for industrial separation and purification of lactoferrin from bovine colostrum | |
| CN116806917B (en) | Fishbone gelatin calcium chelating peptide and preparation method thereof | |
| JPH03240437A (en) | Infant formula similar to human milk | |
| CN101171261A (en) | Immunoglobulin fraction and method thereof | |
| JP3161846B2 (en) | Separation of sialic acid-binding peptides in milk whey | |
| JP2963081B2 (en) | Method for separating and purifying lactoferrin from milk and its by-products | |
| CN118271424B (en) | A method for separating and preparing fresh milk-grade high-purity alpha-lactalbumin | |
| JPS63255299A (en) | Method for separating and purifying lactoferrin from milk | |
| JP2985158B2 (en) | Recovery method of highly active lactenin fraction | |
| WO2024121317A1 (en) | Process for producing a lactoferrin-containing product | |
| JPS59113848A (en) | Purification of whey of concentrated whey protein | |
| CN1546524A (en) | Method for extracting albumin transferrin with iron supplemented and antibacterial function | |
| CN116836257A (en) | Osteopontin purification method | |
| CN104151423B (en) | A kind of lactoferrin preparation method based on casein Yu lactoferrin dynamic adsorption mechanism for resolving |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Ma Chen Document name: Notice of first review |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |